Charles Newbery reported from Pinamar, Argentina, and Simon Romero from Rio de Janeiro.
Thứ Năm, 23 tháng 2, 2012
Argentina Train Crash Kills Dozens and Injures 600
Thứ Hai, 20 tháng 2, 2012
Hepatitis C Now Kills More Americans Than HIV
More Americans now die of hepatitis C than from HIV, the AIDS-causing virus, according to 1999-2007 data reviewed by the U.S. Centers for Disease Control and Prevention (CDC). And most of those dying are middle-aged.
"These data underscore the urgent need to address the health threat posed by chronic hepatitis B and C in the United States," said investigator Dr. Scott Holmberg, chief of the Epidemiology and Surveillance Branch in CDC's Division of Viral Hepatitis.
About 3.2 million Americans are infected with hepatitis C, a major cause of liver cancer and cirrhosis, the CDC authors said. An estimated one-half to three-quarters of infected adults are unaware they have the disease, which progresses slowly.
Hepatitis C is spread through injection drug use, from blood transfusions received before routine blood-screening began in 1992, and through sexual contact. In some cases, it passes from mothers to infants.
"Chronic hepatitis is a leading and preventable cause of premature death in the United States," Holmberg said. "Over time, leaving viral hepatitis untreated can lead to costly care and treatments, and lifetime costs can total hundreds of thousands of dollars. However, early detection and intervention can be cost-effective and save lives."
The new study highlights the need to increase hepatitis awareness and the critical importance of testing, Holmberg said. Screening will increase diagnoses and treatment, thereby reducing hepatitis-related deaths, he said.
The report is published in the Feb. 21 issue of the Annals of Internal Medicine.
Using death records from 1999 to 2007, researchers collected data on some 22 million Americans, looking for those who died from hepatitis B, C and HIV.
The investigators found deaths from hepatitis C surpassed deaths from HIV (15,000 from hepatitis C versus 13,000 from HIV). They also found that deaths from hepatitis C and B are mostly among the middle-aged.
"Seventy-three percent of hepatitis C deaths were reported among those 45 to 64 years old," Holmberg said. "As the population living with hepatitis C in the United States -- 66 percent of whom were born between 1945 and 1964 -- has aged and entered a high-risk period of life for hepatitis C-related disease, deaths associated with hepatitis C have increased substantially."
Vaccines exist for hepatitis B, but not for hepatitis C. If current trends continue, by 2030 deaths from hepatitis C are expected to reach 35,000 a year, researchers say.
According to Dr. Eugene Schiff, director of the Center for Liver Diseases at the University of Miami Miller School of Medicine, "the study is important because it documents and authenticates what we knew." But, "what we need right now, particularly for hepatitis C, is routine screening," noted Schiff, who was not involved with the study.
Dramatic changes are under way in the treatment of hepatitis C, he pointed out. Current treatment involves a cocktail of drugs, including antivirals and interferon, which many people cannot tolerate.
In about two years, interferon-free treatment will be available, Schiff said. This means higher cure rates with fewer side effects, which will make treatment tolerable by most patients, he explained.
"What's going to happen is what happened with HIV -- test and treat," Schiff said. "Patients will be given an interferon-free regimen with cure rates approaching 100 percent," he predicted.
Another study in the same journal issue found that the most up-to-date treatment for hepatitis C can cost $60,000, but may be cost-effective, according to Stanford University health policy researchers.
In a study led by Jeremy Goldhaber-Fiebert, an assistant professor of medicine at the School of Medicine, investigators developed a computer model to assess the cost-effectiveness of a new treatment for hepatitis C. Their model showed that for people with advanced disease the cost was justified in terms of results.
The treatment involves use of two drugs called protease inhibitors -- boceprevir (brand name Victrelis) and telaprevir (brand name Incivek) -- in addition to interferon and an antiviral.
While the new treatment is expensive and may cause side effects, it could reduce patients' risks for cancer and liver transplants, thereby avoiding those costly events and possibly helping patients live longer, better lives, the researchers pointed out in a journal news release.
Yet another study in the journal recommends one-time screening of all those born between 1945 and 1965, instead of waiting until symptoms appear.
More information
For more information on hepatitis, visit the U.S. Centers for Disease Control and Prevention.
Chủ Nhật, 19 tháng 2, 2012
In Mexico, Prison Riot Kills at Least 44 People
Thứ Sáu, 17 tháng 2, 2012
Prison Fire Kills More Than 300 in Honduras
Karla Zabludovsky contributed reporting.
This article has been revised to reflect the following correction:
Correction: February 17, 2012
A picture supplied by Reuters for an article on Thursday about a deadly fire in a Honduran prison was published in error. The news agency said on Thursday that it had removed from circulation the photograph showing two rows of prisoners’ bodies lying on the ground because it believed the picture was taken in 2004 after another prison fire in Honduras, and not after the fire on Wednesday. (Reuters also recalled four other pictures thought to be from the 2004 fire. The Times did not publish any of those.)
Thứ Ba, 7 tháng 2, 2012
Malaria kills twice as many as thought: study
Past studies had overlooked hundreds of thousands of deaths because they had wrongly assumed malaria overwhelmingly killed babies and focused their findings on under-fives, said the study by the Institute for Health Metrics and Evaluation (IHME) in the United States.
The new study, published in The Lancet medical journal, found 42 percent of deaths were actually among older children and adults.
The higher number of victims showed the need to increase funding to fight malaria, even as governments came under pressure to cut their aid budgets amid the global economic crisis, said the researchers.
"You learn in medical school that people exposed to malaria as children develop immunity and rarely die from malaria as adults," said Christopher Murray, who led the study as IHME Director. "What we've found in hospital records, death records, surveys and other sources shows that just is not the case."
In their work, which used new data and computer modelling to build a historical database for malaria between 1980 and 2010, they found that more than 78,000 children aged five to 14, and more than 445,000 people aged 15 and older died from malaria in 2010. This means more than four in 10 of all malaria deaths were in people aged fives years and older.
Overall, malaria deaths worldwide rose from 995,000 in 1980 to a peak of 1.8 million in 2004, before falling again to 1.2 million in 2010, the study found.
The World Health Organisation's (WHO) latest global report said the estimated number of malaria deaths fell to 655,000 in 2010, almost half the number in the IHME study.
The WHO, a United Nations agency, said on Friday it stood by its figures and said that much of the data used in the Lancet study had been based on verbal testimony by relatives of how people had died, not on laboratory diagnosis of samples.
"So we would say that again the great majority of deaths would be in children under five and we stand by our estimates," WHO spokesman Gregory Hartl told a news briefing in Geneva.
Both studies showed a downward trend in deaths in recent years, thanks largely to the use of anti-malaria drugs and insecticide-treated bed nets.
The new findings are part of an ongoing series generated by the Global Burden of Diseases, Injuries and Risk Factors 2010 Study. Global trends in child deaths, maternal deaths, breast cancer, and cervical cancer were released last year
and more will be released in coming months.
Malaria is endemic in more than 100 countries worldwide but can be prevented by the use of bed nets and indoor spraying to keep the mosquitoes that carry the disease at bay.
Effective malaria drugs known as artemisinin-based combination therapies, or ACTs, can cure the infection but access to these medicines is often hampered in poor countries, where funding is limited and health services are patchy.
The IHME researchers said much of the decline in deaths was down to efforts by the Global Fund to Fight AIDS, Malaria and Tuberculosis, which was launched in 2001, and other anti-malaria organisations such as the WHO's Roll Back Malaria campaign.
"We have seen a huge increase in both funding and in policy attention given to malaria over the past decade, and it's having a real impact," said Alan Lopez of the University of Queensland and one of the study's co-authors.
"Reliably demonstrating just how big an impact is important to drive further investments... This makes it even more critical for us to generate accurate estimates for all deaths."
The researchers also warned, as the WHO did in its December 2010 malaria report, that recent gains in the fight against the disease malaria could be reversed if global economic troubles stifle funding efforts.
It said an announcement by the Global Fund in November that it would cancel its next round of funding "casts a cloud over the future of malaria programs".
"If the Global Fund is weakened, the world could lose 40 percent of all the funding dedicated to fighting malaria," said Stephen Lim, also at IHME and a co-author on the study.
Malaria kills twice as many as thought: study
Past studies had overlooked hundreds of thousands of deaths because they had wrongly assumed malaria overwhelmingly killed babies and focused their findings on under-fives, said the study by the Institute for Health Metrics and Evaluation (IHME) in the United States.
The new study, published in The Lancet medical journal, found 42 percent of deaths were actually among older children and adults.
The higher number of victims showed the need to increase funding to fight malaria, even as governments came under pressure to cut their aid budgets amid the global economic crisis, said the researchers.
"You learn in medical school that people exposed to malaria as children develop immunity and rarely die from malaria as adults," said Christopher Murray, who led the study as IHME Director. "What we've found in hospital records, death records, surveys and other sources shows that just is not the case."
In their work, which used new data and computer modelling to build a historical database for malaria between 1980 and 2010, they found that more than 78,000 children aged five to 14, and more than 445,000 people aged 15 and older died from malaria in 2010. This means more than four in 10 of all malaria deaths were in people aged fives years and older.
Overall, malaria deaths worldwide rose from 995,000 in 1980 to a peak of 1.8 million in 2004, before falling again to 1.2 million in 2010, the study found.
The World Health Organisation's (WHO) latest global report said the estimated number of malaria deaths fell to 655,000 in 2010, almost half the number in the IHME study.
The WHO, a United Nations agency, said on Friday it stood by its figures and said that much of the data used in the Lancet study had been based on verbal testimony by relatives of how people had died, not on laboratory diagnosis of samples.
"So we would say that again the great majority of deaths would be in children under five and we stand by our estimates," WHO spokesman Gregory Hartl told a news briefing in Geneva.
Both studies showed a downward trend in deaths in recent years, thanks largely to the use of anti-malaria drugs and insecticide-treated bed nets.
The new findings are part of an ongoing series generated by the Global Burden of Diseases, Injuries and Risk Factors 2010 Study. Global trends in child deaths, maternal deaths, breast cancer, and cervical cancer were released last year
and more will be released in coming months.
Malaria is endemic in more than 100 countries worldwide but can be prevented by the use of bed nets and indoor spraying to keep the mosquitoes that carry the disease at bay.
Effective malaria drugs known as artemisinin-based combination therapies, or ACTs, can cure the infection but access to these medicines is often hampered in poor countries, where funding is limited and health services are patchy.
The IHME researchers said much of the decline in deaths was down to efforts by the Global Fund to Fight AIDS, Malaria and Tuberculosis, which was launched in 2001, and other anti-malaria organisations such as the WHO's Roll Back Malaria campaign.
"We have seen a huge increase in both funding and in policy attention given to malaria over the past decade, and it's having a real impact," said Alan Lopez of the University of Queensland and one of the study's co-authors.
"Reliably demonstrating just how big an impact is important to drive further investments... This makes it even more critical for us to generate accurate estimates for all deaths."
The researchers also warned, as the WHO did in its December 2010 malaria report, that recent gains in the fight against the disease malaria could be reversed if global economic troubles stifle funding efforts.
It said an announcement by the Global Fund in November that it would cancel its next round of funding "casts a cloud over the future of malaria programs".
"If the Global Fund is weakened, the world could lose 40 percent of all the funding dedicated to fighting malaria," said Stephen Lim, also at IHME and a co-author on the study.
Malaria kills twice as many as thought - study
Past studies had overlooked hundreds of thousands of deaths because they had wrongly assumed malaria overwhelmingly killed babies and focused their findings on under-fives, said the study by the Institute for Health Metrics and Evaluation (IHME) in the United States.
The new study, published in The Lancet medical journal, found 42 percent of deaths were actually among older children and adults.
The higher number of victims showed the need to increase funding to fight malaria, even as governments came under pressure to cut their aid budgets amid the global economic crisis, said the researchers.
"You learn in medical school that people exposed to malaria as children develop immunity and rarely die from malaria as adults," said Christopher Murray, who led the study as IHME Director. "What we've found in hospital records, death records, surveys and other sources shows that just is not the case."
In their work, which used new data and computer modelling to build a historical database for malaria between 1980 and 2010, they found that more than 78,000 children aged five to 14, and more than 445,000 people aged 15 and older died from malaria in 2010. This means more than four in 10 of all malaria deaths were in people aged five years and older.
Overall, malaria deaths worldwide rose from 995,000 in 1980 to a peak of 1.8 million in 2004, before falling again to 1.2 million in 2010, the study found.
The World Health Organisation's (WHO) latest global report said the estimated number of malaria deaths fell to 655,000 in 2010, almost half the number in the IHME study.
The WHO, a United Nations agency, said on Friday it stood by its figures and said that much of the data used in the Lancet study had been based on verbal testimony by relatives of how people had died, not on laboratory diagnosis of samples.
"So we would say that again the great majority of deaths would be in children under five and we stand by our estimates," WHO spokesman Gregory Hartl told a news briefing in Geneva.
Both studies showed a downward trend in deaths in recent years, thanks largely to the use of anti-malaria drugs and insecticide-treated bed nets.
The new findings are part of an ongoing series generated by the Global Burden of Diseases, Injuries and Risk Factors 2010 Study. Global trends in child deaths, maternal deaths, breast cancer, and cervical cancer were released last year [ID:nL5E7KF0NP] and more will be released in coming months.
Malaria is endemic in more than 100 countries worldwide but can be prevented by the use of bed nets and indoor spraying to keep the mosquitoes that carry the disease at bay.
Effective malaria drugs known as artemisinin-based combination therapies, or ACTs, can cure the infection but access to these medicines is often hampered in poor countries, where funding is limited and health services are patchy.
The IHME researchers said much of the decline in deaths was down to efforts by the Global Fund to Fight AIDS, Malaria and Tuberculosis, which was launched in 2001, and other anti-malaria organisations such as the WHO's Roll Back Malaria campaign.
"We have seen a huge increase in both funding and in policy attention given to malaria over the past decade, and it's having a real impact," said Alan Lopez of the University of Queensland and one of the study's co-authors.
"Reliably demonstrating just how big an impact is important to drive further investments... This makes it even more critical for us to generate accurate estimates for all deaths."
The researchers also warned, as the WHO did in its December 2010 malaria report, that recent gains in the fight against the disease malaria could be reversed if global economic troubles stifle funding efforts.
It said an announcement by the Global Fund in November that it would cancel its next round of funding "casts a cloud over the future of malaria programs.
"If the Global Fund is weakened, the world could lose 40 percent of all the funding dedicated to fighting malaria," said Stephen Lim, also at IHME and a co-author on the study.
(Additional reporting by Stephanie Nebehay in Geneva; Editing by Andrew Heavens)